scholarly article | Q13442814 |
P356 | DOI | 10.1189/JLB.4A0915-428R |
P8608 | Fatcat ID | release_i7wg54phhng5rneywgrfuh6hgm |
P932 | PMC publication ID | 4952011 |
P698 | PubMed publication ID | 26729813 |
P2093 | author name string | Sarah L Gaffen | |
Ulrich Siebenlist | |||
Elisabetta Traggiai | |||
Natasha Whibley | |||
Frank Kolbinger | |||
Pierre Moulin | |||
Dominique Brees | |||
Abhishek V Garg | |||
Bianca M Coleman | |||
Michael Kammüller | |||
Elaine Tritto | |||
Jillian R Jaycox | |||
Anna J Mamo | |||
P2860 | cites work | Cloning and characterization of IL-17B and IL-17C, two new members of the IL-17 cytokine family | Q22011116 |
IL-17E, a novel proinflammatory ligand for the IL-17 receptor homolog IL-17Rh1 | Q24290462 | ||
Structural basis of receptor sharing by interleukin 17 cytokines | Q24650068 | ||
Mucocutaneous candidiasis: the IL-17 pathway and implications for targeted immunotherapy | Q27010562 | ||
The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing | Q27687800 | ||
CCL28 has dual roles in mucosal immunity as a chemokine with broad-spectrum antimicrobial activity | Q28204353 | ||
Cutting edge: IL-17D, a novel member of the IL-17 family, stimulates cytokine production and inhibits hemopoiesis | Q28208761 | ||
IL-25 induces IL-4, IL-5, and IL-13 and Th2-associated pathologies in vivo | Q28213431 | ||
IL-17RC is required for immune signaling via an extended SEF/IL-17R signaling domain in the cytoplasmic tail | Q28506505 | ||
Dectin-2 recognition of alpha-mannans and induction of Th17 cell differentiation is essential for host defense against Candida albicans | Q28508646 | ||
IL-17B and IL-17C are associated with TNF-alpha production and contribute to the exacerbation of inflammatory arthritis | Q28587556 | ||
Cutting edge: Nlrp10 is essential for protective antifungal adaptive immunity against Candida albicans | Q28591042 | ||
Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome | Q29614595 | ||
Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells | Q29622847 | ||
IL-17A controls IL-17F production and maintains blood neutrophil counts in mice | Q30435495 | ||
Chronic mucocutaneous candidiasis in APECED or thymoma patients correlates with autoimmunity to Th17-associated cytokines | Q33348588 | ||
STAT3 single-nucleotide polymorphisms and STAT3 mutations associated with hyper-IgE syndrome are not responsible for increased serum IgE serum levels in asthma families | Q33374516 | ||
Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I | Q33656182 | ||
Salivary histatin 5 and human neutrophil defensin 1 kill Candida albicans via shared pathways. | Q33980976 | ||
Functional specialization of interleukin-17 family members | Q34025860 | ||
Chronic mucocutaneous candidiasis in humans with inborn errors of interleukin-17 immunity | Q34025875 | ||
Oral-resident natural Th17 cells and γδ T cells control opportunistic Candida albicans infections | Q34230506 | ||
Cytokine and cytokine receptor pleiotropy and redundancy | Q34693494 | ||
IL-23 and IL-17A, but not IL-12 and IL-22, are required for optimal skin host defense against Candida albicans | Q34789143 | ||
Interleukin-17 in rheumatoid arthritis: if T cells were to contribute to inflammation and destruction through synergy | Q35083970 | ||
Mucosal immunity and Candida albicans infection | Q35109998 | ||
Candida-host interactions in HIV disease: implications for oropharyngeal candidiasis | Q35129063 | ||
Inhibition of keratinocyte differentiation by the synergistic effect of IL-17A, IL-22, IL-1α, TNFα and oncostatin M. | Q35204519 | ||
Signaling through IL-17C/IL-17RE is dispensable for immunity to systemic, oral and cutaneous candidiasis | Q35301398 | ||
Inherited IL-17RC deficiency in patients with chronic mucocutaneous candidiasis | Q35568424 | ||
Novel signal transducer and activator of transcription 3 (STAT3) mutations, reduced T(H)17 cell numbers, and variably defective STAT3 phosphorylation in hyper-IgE syndrome | Q36028793 | ||
Neutrophils Do Not Express IL-17A in the Context of Acute Oropharyngeal Candidiasis. | Q36096377 | ||
Interactions between commensal fungi and the C-type lectin receptor Dectin-1 influence colitis | Q36204582 | ||
Interleukin 25 promotes the initiation of proallergic type 2 responses. | Q36229535 | ||
IMMUNODEFICIENCIES. Impairment of immunity to Candida and Mycobacterium in humans with bi-allelic RORC mutations | Q36344921 | ||
Mouse model of oropharyngeal candidiasis | Q36900988 | ||
IL-17A and IL-17F do not contribute vitally to autoimmune neuro-inflammation in mice | Q37036086 | ||
The adaptor protein CIKS/Act1 is essential for IL-25-mediated allergic airway inflammation | Q37070709 | ||
Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis | Q37106755 | ||
The hyper-IgE syndromes | Q37142868 | ||
Th17 cytokines interleukin (IL)-17 and IL-22 modulate distinct inflammatory and keratinocyte-response pathways. | Q37298535 | ||
Defects in Jak-STAT-mediated cytokine signals cause hyper-IgE syndrome: lessons from a primary immunodeficiency | Q37352441 | ||
Th17 cytokines and their emerging roles in inflammation and autoimmunity | Q37374933 | ||
An ACT1 mutation selectively abolishes interleukin-17 responses in humans with chronic mucocutaneous candidiasis | Q37416405 | ||
Interleukin-17-induced protein lipocalin 2 is dispensable for immunity to oral candidiasis. | Q37643893 | ||
Interleukin-17 and its target genes: mechanisms of interleukin-17 function in disease | Q37735334 | ||
Innate immune mechanisms for recognition and uptake of Candida species | Q37779663 | ||
Chronic mucocutaneous candidiasis and congenital susceptibility to Candida | Q37790958 | ||
Targeting IL-17 and TH17 cells in chronic inflammation | Q38047820 | ||
Effect of IL-17A blockade with secukinumab in autoimmune diseases | Q38068701 | ||
The cup runneth over: lessons from the ever-expanding pool of primary immunodeficiency diseases | Q38124223 | ||
Cytokines link osteoblasts and inflammation: microarray analysis of interleukin-17- and TNF-alpha-induced genes in bone cells | Q38333262 | ||
Secukinumab: first global approval | Q38342875 | ||
Orosomucoid, an acute response protein with multiple modulating activities | Q38364856 | ||
Th17 cells confer long-term adaptive immunity to oral mucosal Candida albicans infections | Q39318147 | ||
A novel Th cell epitope of Candida albicans mediates protection from fungal infection | Q39359695 | ||
New model of oropharyngeal candidiasis in mice | Q39478875 | ||
The human IL-17F/IL-17A heterodimeric cytokine signals through the IL-17RA/IL-17RC receptor complex | Q39953231 | ||
Functional Cooperation between Interleukin-17 and Tumor Necrosis Factor-α Is Mediated by CCAAT/Enhancer-binding Protein Family Members | Q40619563 | ||
Evidence that a neutrophil-keratinocyte crosstalk is an early target of IL-17A inhibition in psoriasis | Q41365957 | ||
Orosomucoid 1 drives opportunistic infections through the polarization of monocytes to the M2b phenotype | Q41478869 | ||
Identification of an interleukin 17F/17A heterodimer in activated human CD4+ T cells | Q42170048 | ||
Cutting edge: IL-17-secreting innate lymphoid cells are essential for host defense against fungal infection | Q44653635 | ||
Differential roles of interleukin-17A and -17F in host defense against mucoepithelial bacterial infection and allergic responses. | Q44894318 | ||
Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice | Q45876568 | ||
Genetic origins of hyper-IgE syndrome | Q46444584 | ||
Distinct roles for interleukin-12p40 and tumour necrosis factor in resistance to oral candidiasis defined by gene-targeting | Q48471515 | ||
Secukinumab in plaque psoriasis--results of two phase 3 trials | Q49167189 | ||
Pathogen-induced human TH17 cells produce IFN-γ or IL-10 and are regulated by IL-1β. | Q50959906 | ||
Anti–Interleukin-17 Monoclonal Antibody Ixekizumab in Chronic Plaque Psoriasis | Q58466080 | ||
Brodalumab, an Anti–Interleukin-17–Receptor Antibody for Psoriasis | Q58992083 | ||
IL-17-mediated antifungal defense in the oral mucosa is independent of neutrophils | Q63408304 | ||
An IL-17F/A heterodimer protein is produced by mouse Th17 cells and induces airway neutrophil recruitment | Q79912740 | ||
A novel heterodimeric cytokine consisting of IL-17 and IL-17F regulates inflammatory responses | Q80202735 | ||
P4510 | describes a project that uses | limma | Q112236343 |
P433 | issue | 6 | |
P921 | main subject | antibody | Q79460 |
candidiasis | Q273510 | ||
P304 | page(s) | 1153-1164 | |
P577 | publication date | 2016-01-04 | |
P1433 | published in | Journal of Leukocyte Biology | Q1524048 |
P1476 | title | Antibody blockade of IL-17 family cytokines in immunity to acute murine oral mucosal candidiasis | |
P478 | volume | 99 |